Bridgeway Capital Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,544
| Closed | -$121K | – | 1403 |
|
|
2023
Q1 | $121K | Sell |
9,544
-3,719
| -28% | -$47.3K | ﹤0.01% | 1199 |
|
|
2022
Q4 | $83.8K | Buy |
13,263
+4,063
| +44% | +$25.7K | ﹤0.01% | 1243 |
|
|
2022
Q3 | $208K | Hold |
9,200
| – | – | 0.01% | 1134 |
|
|
2022
Q2 | $177K | Hold |
9,200
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q1 | $427K | Buy |
+9,200
| New | +$427K | 0.01% | 978 |
|
|
2020
Q1 | – | Sell |
-1,893
| Closed | -$459K | – | 1300 |
|
|
2019
Q4 | $459K | Hold |
1,893
| – | – | 0.01% | 1022 |
|
|
2019
Q3 | $311K | Sell |
1,893
-1,562
| -45% | -$257K | ﹤0.01% | 1091 |
|
|
2019
Q2 | $815K | Sell |
3,455
-2,795
| -45% | -$659K | 0.01% | 802 |
|
|
2019
Q1 | $1.65M | Buy |
+6,250
| New | +$1.65M | 0.02% | 600 |
|